First Trust Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $77.2M | Sell |
|
|||||
|
2025
Q2 | $77.5M | Buy |
|
|||||
|
2025
Q1 | $65.6M | Sell |
|
|||||
|
2024
Q4 | $64.1M | Buy |
|
|||||
|
2024
Q3 | $69.8M | Buy |
|
|||||
|
2024
Q2 | $67.9M | Sell |
|
|||||
|
2024
Q1 | $83.4M | Sell |
|
|||||
|
2023
Q4 | $93.7M | Buy |
|
|||||
|
2023
Q3 | $87.7M | Buy |
|
|||||
|
2023
Q2 | $91M | Sell |
|
|||||
|
2023
Q1 | $91.6M | Buy |
|
|||||
|
2022
Q4 | $85.2M | Sell |
|
|||||
|
2022
Q3 | $81.9M | Buy |
|
|||||
|
2022
Q2 | $75.4M | Sell |
|
|||||
|
2022
Q1 | $78.5M | Buy |
|
|||||
|
2021
Q4 | $62.3M | Buy |
|
|||||
|
2021
Q3 | $60.5M | Buy |
|
|||||
|
2021
Q2 | $60.2M | Sell |
|
|||||
|
2021
Q1 | $56.3M | Buy |
|
|||||
|
2020
Q4 | $54M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $223K | Sell |
|
|||||
|
2020
Q1 | $219K | Sell |
|
|||||
|
2019
Q4 | $287K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $17.4M | Buy |
|
|||||
|
2016
Q4 | $15M | Buy |
|
|||||
|
2016
Q3 | $12.6M | Sell |
|
|||||
|
2016
Q2 | $11.6M | Buy |
|
|||||
|
2016
Q1 | $8.31M | Buy |
|
|||||
|
2015
Q4 | $7.76M | Buy |
|
|||||
|
2015
Q3 | $4.99M | Sell |
|
|||||
|
2015
Q2 | $5.81M | Sell |
|
|||||
|
2015
Q1 | $6.54M | Sell |
|
|||||
|
2014
Q4 | $6.89M | Buy |
|
|||||
|
2014
Q3 | $5.84M | Buy |
|
|||||
|
2014
Q2 | $5.61M | Sell |
|
|||||
|
2014
Q1 | $5.69M | Sell |
|
|||||
|
2013
Q4 | $5.35M | Sell |
|
|||||
|
2013
Q3 | $5.04M | Buy |
|
|||||
|
2013
Q2 | $4.49M | Buy |
|